Phoenix New Media Limited (NYSE:FENG)
Phoenix New Media Limited (NYSE:FENG) represented a move of 0 percent or $0.1 per share and closed its previous day trading session at $3.53. 0 Shares were traded in the last trading session with an Average Volume of 196.46 Million Shares. The stock currently has a Market Capitalization of 263.9 Million.
Phoenix New Media Limited provides premium content on an integrated platform across Internet, mobile and TV channels in China. The Company provides global news coverage, investigative reports and in-depth analysis of events in compelling presentation formats. It enable consumers to access professional news and other quality content and share user-generated content, or UGC, on the Internet and through their mobile devices. Phoenix New Media Limited is a subsidiary of Phoenix Satellite Television (B.V.I.) Holding Limited and is based in Beijing, the Peoples’ Republic of China.
The stock traded between $3.06 and $7.42 over 1-Year time period showing its price to sales ratio of 1.27. Phoenix New Media Limited (NYSE:FENG) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-0.27 and 200-Day Simple Moving Average of $-18.65. Its Price to Free Cash Flow is 0 and Price to Book of 0.67.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Phoenix New Media Limited (NYSE:FENG) reported its Actual EPS of $-0.04/share. The analysts offering Earnings Estimates for the company were believing that Phoenix New Media Limited could bring EPS of $0.04/share. The difference between Actual EPS and Estimated EPS was -0.08 Percent. Thus showing an Earnings Surprise of -200 Percent.
AmpliPhi Biosciences Corporation (NYSE:APHB)
In the last trading session, AmpliPhi Biosciences Corporation (NYSE:APHB) added its value by 0% closing at the price of $0.24. The stock currently has market capitalization of 7.14 Million, with average volume of 620.12 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently AmpliPhi Biosciences Corporation (NYSE:APHB) is showing beta of 2.15. This particular value of beta suggests that AmpliPhi Biosciences Corporation (NYSE:APHB) has historically moved 215% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for AmpliPhi Biosciences Corporation (NYSE:APHB) is at $-0.76.
The stock currently has RSI of 22.69. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
AmpliPhi Biosciences Corporation, formerly known as Targeted Genetics Corporation, is a biotechnology company which develops anti-bacterial solutions for the treatment of gram negative bacterial infections that are often resistant to existing antibiotic treatments. AmpliPhi Biosciences Corporation is based in Seattle, Washington.
AmpliPhi Biosciences Corporation (NYSE:APHB) topped its 52-week high price of $2.050 on 01/08/18 and 52-Week Low Price of $0.210 on 11/28/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 14.68% and monthly volatility of 12.19% respectively.